HADLIMA® (adalimumab

"Moderate to severe rheumatoid arthritis (RA) in adults. HADLIMA can be used alone, with methotrexate, or with certain other medicines." That is how HADLIMA® (adalimumab introduces itself. To AI engines like ChatGPT and Perplexity it is partially visible, scoring 5.1 out of 10, readable in places and missing in others.

On the page itself the strengths are clear: a clear heading structure, crawler access and the files AI engines look for and sitemaps and entity links AI can follow. What holds it back is structured data describing the business, a clearly stated business identity and credibility markers like credentials or reviews.

Away from its own site, other sites link to it. There is some, but not much, sign that the domain is only lightly established. Beyond that, AI engines do not yet recognise it as a distinct business, there is no press coverage to draw on, nobody is discussing it where AI engines look and it does not come up on Reddit. Those are earned elsewhere on the web, not fixed on the site itself.

AI crawlers have visited once in our tracking, including ClaudeBot (Anthropic). The site links to no social profiles, so there is nothing tying the brand to a wider presence.